These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20683890)

  • 1. On the limitations of comparative effectiveness research.
    Rubin DB
    Stat Med; 2010 Aug; 29(19):1991-5; discussion 1996-7. PubMed ID: 20683890
    [No Abstract]   [Full Text] [Related]  

  • 2. The promise and realities of comparative effectiveness research.
    Gatsonis C
    Stat Med; 2010 Aug; 29(19):1977-81; discussion 1996-7. PubMed ID: 20683886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is evidence?
    Normand SL; McNeil BJ
    Stat Med; 2010 Aug; 29(19):1985-8; discussion 1996-7. PubMed ID: 20683888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisiting issues, drawbacks and opportunities with observational studies in comparative effectiveness research.
    Alemayehu D; Cappelleri JC
    J Eval Clin Pract; 2013 Aug; 19(4):579-83. PubMed ID: 22128798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The historical and moral imperatives of comparative effectiveness research.
    Lauer MS
    Stat Med; 2010 Aug; 29(19):1982-4; discussion 1996-7. PubMed ID: 20683887
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative effectiveness research: Policy context, methods development and research infrastructure.
    Tunis SR; Benner J; McClellan M
    Stat Med; 2010 Aug; 29(19):1963-76. PubMed ID: 20564311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facts, fallacies, and politics of comparative effectiveness research: Part I. Basic considerations.
    Manchikanti L; Falco FJ; Boswell MV; Hirsch JA
    Pain Physician; 2010; 13(1):E23-54. PubMed ID: 20119474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report--Part II.
    Cox E; Martin BC; Van Staa T; Garbe E; Siebert U; Johnson ML
    Value Health; 2009; 12(8):1053-61. PubMed ID: 19744292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comments on 'Comparative effectiveness research: Policy context, methods development and research infrastructure'.
    Morton SC
    Stat Med; 2010 Aug; 29(19):1989-90; discussion 1996-7. PubMed ID: 20683889
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative effectiveness research - the missing link in evidence-informed clinical medicine and health care policy making.
    Scott IA
    Med J Aust; 2013 Apr; 198(6):310-2. PubMed ID: 23545024
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative effectiveness research: a view from the other side of the pond.
    Rawlins MD
    J Comp Eff Res; 2012 May; 1(3):293-5. PubMed ID: 24237410
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative Effectiveness Research and the Surveillance, Epidemiology, and End Results database: what is Comparative Effectiveness Research (CER) and why is it important?
    Yu JB; Lloyd S; Decker RH; Wilson LD; Park HS
    Curr Probl Cancer; 2012; 36(4):208-15. PubMed ID: 22481005
    [No Abstract]   [Full Text] [Related]  

  • 13. A flexible approach to evidentiary standards for comparative effectiveness research.
    Garrison LP; Neumann PJ; Radensky P; Walcoff SD
    Health Aff (Millwood); 2010 Oct; 29(10):1812-7. PubMed ID: 20921480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facts, fallacies, and politics of comparative effectiveness research: Part 2 - implications for interventional pain management.
    Manchikanti L; Falco FJ; Boswell MV; Hirsch JA
    Pain Physician; 2010; 13(1):E55-79. PubMed ID: 20119475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translating comparative effectiveness research into Medicaid payment policy: views from medical and pharmacy directors.
    Weissman JS; Westrich K; Hargraves JL; Pearson SD; Dubois R; Emond S; Olufajo OA
    J Comp Eff Res; 2015 Mar; 4(2):79-88. PubMed ID: 25825839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On guidelines for comparative effectiveness research using nonrandomized studies in secondary data sources.
    Schneeweiss S
    Value Health; 2009; 12(8):1041. PubMed ID: 19744290
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative effectiveness research in neurotrauma.
    Timmons SD; Toms SA
    Neurosurg Focus; 2012 Jul; 33(1):E3. PubMed ID: 22746235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
    McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D
    Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory considerations in the design of comparative observational studies using propensity scores.
    Yue LQ
    J Biopharm Stat; 2012; 22(6):1272-9. PubMed ID: 23075022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invited article: comparative effectiveness research, evidence-based medicine, and the AAN.
    French JA; England JD
    Neurology; 2010 Aug; 75(6):562-7. PubMed ID: 20697109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.